🇺🇸 FDA
Patent

US 12077601

Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

granted A61PA61P17/02A61P21/04

Quick answer

US patent 12077601 (Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods) held by BANYAN BIOMARKERS, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BANYAN BIOMARKERS, INC.
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P17/02, A61P21/04, A61P25/00, A61P25/16